MaineGeneral Health is accusing manufacturers and pharmacy benefit managers of driving up insulin prices 1,000 percent over two decades.
MaineGeneral Health is accusing manufacturers and pharmacy benefit managers of driving up insulin prices 1,000 percent over two decades.
